Pharmaceutical: Top Companies by Equity ratio

Top 83 of 83 companies in Pharmaceutical reporting this metric

Equity ratio = owners' equity (excluding non-controlling interests) ÷ total assets.

Industry spread

25th percentile
50.7%
Median
69.7%
75th percentile
84.8%

Latest annual figures of the 83 companies in Pharmaceutical that report this metric.

RankCompanyValue
14893 Noile-Immune Biotech Inc. 97.8% FY2025
24891 TMS Co., Ltd. 95.5% FY2025 (10 months)
34591 RIBOMIC Inc. 95.4% FY2025
4130A Veritas In Silico Inc. 94.6% FY2025
54889 Renascience Inc. 94.5% FY2025
6219A Heartseed Inc. 93.7% FY2024 (14 months)
74883 Modalis Therapeutics Corporation 93.0% FY2025
84586 Medrx Co., Ltd. 92.2% FY2025
94596 Kubota Pharmaceutical Holdings Co., Ltd. 91.6% FY2025
104894 Cuorips Inc. 91.6% FY2025
11190A Chordia Therapeutics Inc. 90.8% FY2024
124575 CanBas Co., Ltd. 90.2% FY2025
134594 BrightPath Biotherapeutics Co., Ltd. 90.1% FY2025
144564 OncoTherapy Science, Inc. 87.8% FY2025
154588 Oncolys BioPharma Inc. 87.6% FY2025
16206A PRISM BioLab Co.,LTD 87.6% FY2024
174548 SEIKAGAKU CORPORATION 87.2% FY2025
184551 TORII PHARMACEUTICAL CO., LTD. 86.4% FY2024
194570 Immuno-Biological Laboratories Co., Ltd. 85.5% FY2025
204592 SanBio Company Limited 85.4% FY2025
21520A J-Pharma Co.,Ltd. 85.4% FY2025
224516 Nippon Shinyaku Co., Ltd. 84.2% FY2025
234547 KISSEI PHARMACEUTICAL CO., LTD. 83.7% FY2025
244595 MIZUHO MEDY CO.,LTD. 83.5% FY2025
254521 KAKEN PHARMACEUTICAL CO., LTD. 82.8% FY2025
264519 CHUGAI PHARMACEUTICAL CO., LTD. 82.1% FY2025
274151 Kyowa Kirin Co., Ltd. 80.6% FY2025
284530 HISAMITSU PHARMACEUTICAL CO.,INC. 80.6% FY2024
299273 KOA SHOJI HOLDINGS CO.,LTD. 78.9% FY2025
304599 StemRIM Inc. 78.0% FY2024
314556 KAINOS Laboratories,Inc. 77.1% FY2024
324528 ONO PHARMACEUTICAL CO., LTD. 76.9% FY2025
334534 Mochida Pharmaceutical Co.,Ltd. 76.8% FY2025
344569 KYORIN Pharmaceutical Co., Ltd. 72.9% FY2025
354512 WAKAMOTO PHARMACEUTICAL CO.,LTD. 72.8% FY2025
364881 FunPep Company Limited 72.7% FY2025
374578 Otsuka Holdings Co., Ltd. 72.3% FY2025
384577 Daito Pharmaceutical Co.,Ltd. 72.2% FY2025
394536 SANTEN PHARMACEUTICAL CO., LTD. 70.2% FY2025
404549 EIKEN CHEMICAL CO.,LTD. 70.1% FY2025
414882 Perseus Proteomics Inc. 70.1% FY2025
424524 MORISHITA JINTAN CO., LTD. 69.7% FY2025
434574 TAIKO PHARMACEUTICAL CO.,LTD. 69.4% FY2025
444587 PeptiDream Inc. 66.9% FY2025
45177A Kohjin Bio Co., Ltd. 66.8% FY2025
464576 D.Western Therapeutics Institute, Inc. 66.1% FY2025
474507 Shionogi & Co., Ltd. 65.4% FY2025
484579 RaQualia Pharma Inc. 65.1% FY2025
494583 Chiome Bioscience Inc. 64.1% FY2025
504886 ASKA Pharmaceutical Holdings Co., Ltd. 62.6% FY2025
514892 Cyfuse Biomedical K.K. 62.3% FY2025
524527 ROHTO PHARMACEUTICAL CO.,LTD. 62.1% FY2025
534523 Eisai Co., Ltd. 62.0% FY2025
544884 Kringle Pharma, Inc. 61.5% FY2024
554559 ZERIA PHARMACEUTICAL CO., LTD. 60.3% FY2025
562160 GNI Group Ltd. 60.1% FY2025
574571 Nano Holdings, Inc. 59.9% FY2025
584563 AnGes, Inc. 55.2% FY2025
594540 TSUMURA & CO. 54.3% FY2025
604888 STELLA PHARMA CORPORATION 54.1% FY2025
614531 YUKI GOSEI KOGYO CO., LTD. 52.4% FY2025
624503 Astellas Pharma Inc. 51.3% FY2025
634554 Fuji Pharma Co.,Ltd. 50.2% FY2024
644887 SAWAI GROUP HOLDINGS Co., Ltd. 49.6% FY2025
654558 CHUKYOIYAKUHIN CO.,LTD. 48.8% FY2025
664502 Takeda Pharmaceutical Company Limited 47.9% FY2025
674565 Nxera Pharma Co., Ltd. 45.3% FY2025
68197A TAUNS Laboratories,Inc. 43.5% FY2025
694896 K Pharma,Inc. 43.1% FY2025
704552 JCR Pharmaceuticals Co.,Ltd. 42.9% FY2025
714568 DAIICHI SANKYO COMPANY, LIMITED 42.1% FY2025
724885 MUROMACHI CHEMICALS INC. 40.6% FY2025
734539 NIPPON CHEMIPHAR CO., LTD. 39.0% FY2025
744538 Fuso Pharmaceutical Industries, Ltd. 38.8% FY2025
754553 TOWA PHARMACEUTICAL CO., LTD. 37.5% FY2025
764506 Sumitomo Pharma Co., Ltd. 36.4% FY2025
777096 StemCell Institute Inc. 33.0% FY2025
784593 HEALIOS K.K. 28.7% FY2025
794584 Kidswell Bio Corporation 26.4% FY2025
804572 Carna Biosciences, Inc. 25.1% FY2025
814582 SymBio Pharmaceuticals Limited 23.9% FY2025
824598 Delta-Fly Pharma, Inc. 12.6% FY2025
83504A Innovacell Inc. -51.7% FY2025